AlzeCure Pharma AB (publ) (STO:ALZCUR)
Sweden · Delayed Price · Currency is SEK 3.960
-1.180 (-22.96%)
Jun 11, 2026, 5:29 PM CET
AlzeCure Pharma AB Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
10
Market Cap
455.06M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cantargia AB | 317.21M |
| Sprint Bioscience AB | 153.28M |
| Oncopeptides AB | 83.24M |
| Intervacc AB | 19.07M |
| Corline Biomedical AB | 10.67M |
| Medivir AB | 9.01M |
| Xspray Pharma AB | 2.47M |
| FluoGuide | 349.42K |
AlzeCure Pharma AB News
- 16 days ago - AlzeCure Pharma AB Transcript: Study update - Transcripts
- 16 days ago - AlzeCure Pharma AB Press release: Study update - Filings
- 16 days ago - AlzeCure Pharma AB Slides: Study update - Filings
- 5 weeks ago - AlzeCure Pharma AB Quarterly report: Q1 2026 - Filings
- 3 months ago - AlzeCure Pharma AB Annual report: Q4 2025 - Filings
- 3 months ago - AlzeCure Pharma AB Quarterly report: Q4 2025 - Filings
- 7 months ago - AlzeCure Pharma AB Quarterly report: Q3 2025 - Filings
- 10 months ago - AlzeCure Pharma AB Transcript: Status Update - Transcripts